ME Therapeutics Holdings Inc.
METXF
$2.95
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.45% | 39.49% | 236.63% | 131.98% | 160.52% |
| Total Receivables | 155.21% | 186.44% | -16.67% | 132.08% | 113.33% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 816.00% | 615.25% | 40.98% | 46.09% | 66.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.32% | 43.74% | 195.82% | 129.77% | 159.77% |
|
|
|||||
| Total Current Assets | 5.32% | 43.74% | 195.82% | 129.77% | 159.77% |
| Net Property, Plant & Equipment | 165,900.00% | 170,000.00% | 79,700.00% | 0.00% | -50.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 19.50% | 61.41% | 220.99% | 129.74% | 159.68% |
|
|
|||||
| Total Accounts Payable | 229.70% | -- | 135.90% | -56.60% | -81.64% |
| Total Accrued Expenses | -10.28% | -- | 2,190.00% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 29.15% | -- | -- |
| Total Finance Division Other Current Liabilities | 296.30% | -- | -- | 853.85% | 3.85% |
| Total Other Current Liabilities | 296.30% | -- | -- | 853.85% | 3.85% |
| Total Current Liabilities | 207.58% | -- | 116.58% | -57.52% | -60.62% |
|
|
|||||
| Total Current Liabilities | 207.58% | -- | 116.58% | -57.52% | -60.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 264.72% | -- | 187.39% | -57.52% | -60.62% |
|
|
|||||
| Common Stock & APIC | 39.40% | 77.28% | 30.89% | 35.52% | 38.07% |
| Retained Earnings | -13.26% | -9.98% | -12.88% | -18.25% | -90.73% |
| Treasury Stock & Other | -29.86% | -45.20% | 13.70% | 20.72% | 811.55% |
| Total Common Equity | 12.44% | 51.39% | 227.72% | 182.88% | 209.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.44% | 51.39% | 227.72% | 182.88% | 209.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.44% | 51.39% | 227.72% | 182.88% | 209.57% |
|
|
|||||